Antihypertensive Drugs Market Research Report Information By Therapeutic Class (Calcium Channel Blockers, Beta-adrenergic Blockers, Renin Inhibitors, ACE Inhibitors, Vasodilators, Diuretics, ARBs, and Others), By Type (Primary Hypertension, Secondary Hypertension), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-commerce Websites, Online Drug Stores, and Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032

1 Report Prologue

2 Executive Summary

3 Market Introduction

3.1 Definition 17

3.2 Scope of the Study 17

3.3 List of Assumptions 17

3.4 Market Structure 18

4 Research Methodology

4.1 Research Process 20

4.2 Primary Research 20

4.3 Secondary Research 21

4.4 Market Size Estimation 22

4.5 Forecast Model 22

5 Market Dynamics

5.1 Overview 24

5.2 Drivers 24

5.2.1 Rising prevalence of hypertension 24

5.2.2 Growing initiatives by private and government organizations 24

5.2.3 Rise in the prevalence rates of chronic diseases 25

5.2.4 Increasing penetration of generic versions of drugs 25

5.3 Restraints 25

5.3.1 Side-effects of treatment options 25

5.3.2 High cost of treatment 25

5.3.3 Loss of patents 25

5.3.4 Rise in non-pharmacological therapy 25

5.4 Opportunity 26

5.4.1 Emerging therapies in the treatment hypertension 26

6 Market Factor Analysis

6.1 Value chain analysis 28

6.1.1 R&D and Designing 28

6.1.2 Manufacturing 28

6.1.3 Distribution & Sales 28

6.1.4 Post Sales Review 28

6.2 Porter’s Five Forces Model 29

6.2.1 Bargaining Power of Suppliers 29

6.2.1 Bargaining Power of Buyers 30

6.2.2 Threat of New Entrants 30

6.2.3 Threat of Substitutes 30

6.2.4 Intense Rivalry 30

6.3 Investment Opportunities 30

6.4 Pricing Analysis 31

7 Antihypertensive Drugs Market, by Therapeutic Class

7.1 Overview 33

7.2 Diuretics 34

7.3 ACE Inhibitors 35

7.4 ARBs 36

7.5 Calcium Channel Blockers 37

7.6 Beta-Adrenergic Blockers 38

7.7 Renin Inhibitors 39

7.8 Vasodilators 39

7.9 Others 40

8 Antihypertensive Drugs Market, by Type

8.1 Overview 42

8.2 Primary Hypertension 43

8.3 Secondary Hypertension 44

9 Antihypertensive Drugs Market, by Distribution Channel

9.1 Overview 46

9.2 Retail Pharmacy 47

9.3 Hospital Pharmacy 47

9.4 E-commerce Websites & Online Drug Stores 48

9.5 Others 48

10 Global Antihypertensive Drugs Market, by Region

10.1 Overview 50

10.2 Americas 51

Antihypertensive Drugs Market, by Therapeutic Class

Antihypertensive Drugs Market, by Type

Antihypertensive Drugs Market, by Distribution Channel

10.2.1 North America 53

Antihypertensive Drugs Market, by Therapeutic Class

Antihypertensive Drugs Market, by Type

Antihypertensive Drugs Market, by Distribution Channel

10.2.1.1 US 56

Antihypertensive Drugs Market, by Therapeutic Class

Antihypertensive Drugs Market, by Type

Antihypertensive Drugs Market, by Distribution Channel

10.2.1.2 Canada 57

Antihypertensive Drugs Market, by Therapeutic Class

Antihypertensive Drugs Market, by Type

Antihypertensive Drugs Market, by Distribution Channel

10.2.2 Latin America 59

Antihypertensive Drugs Market, by Therapeutic Class

Antihypertensive Drugs Market, by Type

Antihypertensive Drugs Market, by Distribution Channel

10.3 Europe 61

Antihypertensive Drugs Market, by Therapeutic Class

Antihypertensive Drugs Market, by Type

Antihypertensive Drugs Market, by Distribution Channel

10.3.1 Western Europe 63

Antihypertensive Drugs Market, by Therapeutic Class

Antihypertensive Drugs Market, by Type

Antihypertensive Drugs Market, by Distribution Channel

10.3.1.1 Germany 66

Antihypertensive Drugs Market, by Therapeutic Class

Antihypertensive Drugs Market, by Type

Antihypertensive Drugs Market, by Distribution Channel

10.3.1.2 France 67

Antihypertensive Drugs Market, by Therapeutic Class

Antihypertensive Drugs Market, by Type

Antihypertensive Drugs Market, by Distribution Channel

10.3.1.3 UK 69

Antihypertensive Drugs Market, by Therapeutic Class

Antihypertensive Drugs Market, by Type

Antihypertensive Drugs Market, by Distribution Channel

10.3.1.4 Italy 70

Antihypertensive Drugs Market, by Therapeutic Class

Antihypertensive Drugs Market, by Type

Antihypertensive Drugs Market, by Distribution Channel

10.3.1.5 Spain 72

Antihypertensive Drugs Market, by Therapeutic Class

Antihypertensive Drugs Market, by Type

Antihypertensive Drugs Market, by Distribution Channel

10.3.1.6 Rest of Western Europe 73

Antihypertensive Drugs Market, by Therapeutic Class

Antihypertensive Drugs Market, by Type

Antihypertensive Drugs Market, by Distribution Channel

10.3.2 Eastern Europe 75

Antihypertensive Drugs Market, by Therapeutic Class

Antihypertensive Drugs Market, by Type

Antihypertensive Drugs Market, by Distribution Channel

10.4 Asia-Pacific 77

Antihypertensive Drugs Market, by Therapeutic Class

Antihypertensive Drugs Market, by Type

Antihypertensive Drugs Market, by Distribution Channel

10.4.1 Japan 79

Antihypertensive Drugs Market, by Therapeutic Class

Antihypertensive Drugs Market, by Type

Antihypertensive Drugs Market, by Distribution Channel

10.4.2 China 81

Antihypertensive Drugs Market, by Therapeutic Class

Antihypertensive Drugs Market, by Type

Antihypertensive Drugs Market, by Distribution Channel

10.4.3 India 82

Antihypertensive Drugs Market, by Therapeutic Class

Antihypertensive Drugs Market, by Type

Antihypertensive Drugs Market, by Distribution Channel

10.4.4 Australia 84

Antihypertensive Drugs Market, by Therapeutic Class

Antihypertensive Drugs Market, by Type

Antihypertensive Drugs Market, by Distribution Channel

10.4.5 South Korea 85

Antihypertensive Drugs Market, by Therapeutic Class

Antihypertensive Drugs Market, by Type

Antihypertensive Drugs Market, by Distribution Channel

10.4.6 Rest of Asia-Pacific 87

Antihypertensive Drugs Market, by Therapeutic Class

Antihypertensive Drugs Market, by Type

Antihypertensive Drugs Market, by Distribution Channel

10.5 Middle East & Africa 89

Antihypertensive Drugs Market, by Therapeutic Class

Antihypertensive Drugs Market, by Type

Antihypertensive Drugs Market, by Distribution Channel

10.5.1 Middle East 91

Antihypertensive Drugs Market, by Therapeutic Class

Antihypertensive Drugs Market, by Type

Antihypertensive Drugs Market, by Distribution Channel

10.5.2 Africa 93

Antihypertensive Drugs Market, by Therapeutic Class

Antihypertensive Drugs Market, by Type

Antihypertensive Drugs Market, by Distribution Channel

11 Competitive Landscape

11.1 Overview 96

11.2 Company Share Analysis 96

12 Company Profile

12.1 Sanofi S. A. 99

12.1.1 Company Overview 99

12.1.2 Financial Overview 99

12.1.3 Products Offered 100

12.1.4 SWOT Analysis 100

12.1.5 Key Developments 100

12.1.6 Key strategy 100

12.2 Novartis AG 101

12.2.1 Company Overview 101

12.2.2 Financial Overview 101

12.2.3 Products Offered 102

12.2.4 SWOT Analysis 102

12.2.5 Key Developments 102

12.2.6 Key strategy 102

12.3 AstraZeneca 103

12.3.1 Company Overview 103

12.3.2 Financial Overview 103

12.3.3 Products Offered 104

12.3.4 SWOT Analysis 104

12.3.5 Key Developments 104

12.3.6 Key strategy 104

12.4 Daiichi Sankyo Company, Ltd 105

12.4.1 Company Overview 105

12.4.2 Financial Overview 105

12.4.3 Products Offered 106

12.4.4 SWOT Analysis 106

12.4.5 Key Developments 106

12.4.6 Key Strategy 106

12.5 Boehringer Ingelheim GmbH 107

12.5.1 Company Overview 107

12.5.2 Financial Overview 107

12.5.3 Products Offered 108

12.5.4 SWOT Analysis 108

12.5.5 Key Developments 108

12.5.6 Key Strategy 108

12.6 Takeda Pharmaceutical Company Ltd 109

12.6.1 Company Overview 109

12.6.2 Financial Overview 109

12.6.3 Products Offered 109

12.6.4 SWOT Analysis 110

12.6.5 Key Developments 110

12.6.6 Key Strategy 110

12.7 Merck KGaA 111

12.7.1 Company Overview 111

12.7.2 Financial Overview 111

12.7.3 Products Offered 111

12.7.4 SWOT Analysis 112

12.7.5 Key Developments 112

12.7.6 Key Strategy 112

12.8 Johnson & Johnson Services, Inc. 113

12.8.1 Company Overview 113

12.8.2 Financial Overview 113

12.8.3 Products Offered 114

12.8.4 SWOT Analysis 114

12.8.5 Key Developments 114

12.8.6 Key Strategy 114

12.9 Bayer AG 115

12.9.1 Company Overview 115

12.9.2 Financial Overview 115

12.9.3 Products Offered 115

12.9.4 SWOT Analysis 116

12.9.5 Key Developments 116

12.9.6 Key Strategy 116

12.10 Pfizer, Inc. 117

12.10.1 Company Overview 117

12.10.2 Financial Overview 117

12.10.3 Products Offered 118

12.10.4 SWOT Analysis 118

12.10.5 Key Developments 118

12.10.6 Key Strategy 118

12.11 United Therapeutics Corporation 119

12.11.1 Company Overview 119

12.11.2 Financial Overview 119

12.11.3 Products Offered 120

12.11.4 SWOT Analysis 120

12.11.5 Key Developments 120

12.11.6 Key Strategy 120

13 Appendix

13.1 Discussion Blue Print 122

14 List of Tables

TABLE 1 MARKET SYNOPSIS 15

TABLE 2 LIST OF ASSUMPTIONS 17

TABLE 3 GLOBAL ANTIHYPERTENSIVE DRUGS MARKET, BY THERAPEUTIC CLASS, 2020–2027 (USD MILLION) 33

TABLE 4 GLOBAL ANTIHYPERTENSIVE DRUGS MARKET FOR DIURETICS, BY REGION, 2020–2027 (USD MILLION) 34

TABLE 5 GLOBAL ANTIHYPERTENSIVE DRUGS MARKET FOR ACE INHIBITORS, BY REGION, 2020–2027 (USD MILLION) 35

TABLE 6 GLOBAL ANTIHYPERTENSIVE DRUGS MARKET FOR ARBS, BY REGION, 2020–2027 (USD MILLION) 36

TABLE 7 GLOBAL ANTIHYPERTENSIVE DRUGS MARKET FOR CALCIUM CHANNEL BLOCKERS, BY REGION, 2020–2027 (USD MILLION) 37

TABLE 8 GLOBAL ANTIHYPERTENSIVE DRUGS MARKET FOR BETA-ADRENERGIC BLOCKERS, BY REGION, 2020–2027 (USD MILLION) 38

TABLE 9 GLOBAL ANTIHYPERTENSIVE DRUGS MARKET FOR RENIN INHIBITORS, BY REGION, 2020–2027 (USD MILLION) 39

TABLE 10 GLOBAL ANTIHYPERTENSIVE DRUGS MARKET FOR VASODILATORS, BY REGION, 2020–2027 (USD MILLION) 39

TABLE 11 GLOBAL ANTIHYPERTENSIVE DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 42

TABLE 12 GLOBAL ANTIHYPERTENSIVE DRUGS MARKET FOR PRIMARY HYPERTENSION, BY REGION, 2020–2027 (USD MILLION) 43

TABLE 13 GLOBAL ANTIHYPERTENSIVE DRUGS MARKET FOR SECONDARY HYPERTENSION, BY REGION, 2020–2027 (USD MILLION) 44

TABLE 14 GLOBAL ANTIHYPERTENSIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 46

TABLE 15 GLOBAL ANTIHYPERTENSIVE DRUGS MARKET FOR RETAIL PHARMACY, BY REGION, 2020–2027 (USD MILLION) 47

TABLE 16 GLOBAL ANTIHYPERTENSIVE DRUGS MARKET FOR HOSPITAL PHARMACY, BY REGION, 2020–2027 (USD MILLION) 47

TABLE 17 GLOBAL ANTIHYPERTENSIVE DRUGS MARKET FOR E-COMMERCE WEBSITES AND ONLINE DRUG STORES, BY REGION, 2020–2027 (USD MILLION) 48

TABLE 18 GLOBAL ANTIHYPERTENSIVE DRUGS MARKET, BY REGION, 2020–2027 (USD MILLION) 50

TABLE 19 AMERICAS: ANTIHYPERTENSIVE DRUGS MARKET, BY REGION, 2020–2027 (USD MILLION) 51

TABLE 20 AMERICAS: ANTIHYPERTENSIVE DRUGS MARKET, BY THERAPEUTIC CLASS, 2020–2027 (USD MILLION) 52

TABLE 21 AMERICAS: ANTIHYPERTENSIVE DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 52

TABLE 22 AMERICAS: ANTIHYPERTENSIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 53

TABLE 23 NORTH AMERICA: ANTIHYPERTENSIVE DRUGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 54

TABLE 24 NORTH AMERICA: ANTIHYPERTENSIVE DRUGS MARKET, BY THERAPEUTIC CLASS, 2020–2027 (USD MILLION) 54

TABLE 25 NORTH AMERICA: ANTIHYPERTENSIVE DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 55

TABLE 26 NORTH AMERICA: ANTIHYPERTENSIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 55

TABLE 27 US: ANTIHYPERTENSIVE DRUGS MARKET, BY THERAPEUTIC CLASS, 2020–2027 (USD MILLION) 56

TABLE 28 US: ANTIHYPERTENSIVE DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 56

TABLE 29 US: ANTIHYPERTENSIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 57

TABLE 30 CANADA: ANTIHYPERTENSIVE DRUGS MARKET, BY THERAPEUTIC CLASS, 2020–2027 (USD MILLION) 57

TABLE 31 CANADA: ANTIHYPERTENSIVE DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 58

TABLE 32 CANADA: ANTIHYPERTENSIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 58

TABLE 33 LATIN AMERICA: ANTIHYPERTENSIVE DRUGS MARKET, BY THERAPEUTIC CLASS, 2020–2027 (USD MILLION) 59

TABLE 34 LATIN AMERICA: ANTIHYPERTENSIVE DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 59

TABLE 35 LATIN AMERICA: ANTIHYPERTENSIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 60

TABLE 36 EUROPE: ANTIHYPERTENSIVE DRUGS MARKET, BY REGION, 2020–2027 (USD MILLION) 61

TABLE 37 EUROPE: ANTIHYPERTENSIVE DRUGS MARKET, BY THERAPEUTIC CLASS, 2020–2027 (USD MILLION) 62

TABLE 38 EUROPE: ANTIHYPERTENSIVE DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 62

TABLE 39 EUROPE: ANTIHYPERTENSIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 63

TABLE 40 WESTERN EUROPE: ANTIHYPERTENSIVE DRUGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 64

TABLE 41 WESTERN EUROPE: ANTIHYPERTENSIVE DRUGS MARKET, BY THERAPEUTIC CLASS, 2020–2027 (USD MILLION) 64

TABLE 42 WESTERN EUROPE: ANTIHYPERTENSIVE DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 65

TABLE 43 WESTERN EUROPE: ANTIHYPERTENSIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 65

TABLE 44 GERMANY: ANTIHYPERTENSIVE DRUGS MARKET, BY THERAPEUTIC CLASS, 2020–2027 (USD MILLION) 66

TABLE 45 GERMANY: ANTIHYPERTENSIVE DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 66

TABLE 46 GERMANY: ANTIHYPERTENSIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 67

TABLE 47 FRANCE: ANTIHYPERTENSIVE DRUGS MARKET, BY THERAPEUTIC CLASS, 2020–2027 (USD MILLION) 67

TABLE 48 FRANCE: ANTIHYPERTENSIVE DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 68

TABLE 49 FRANCE: ANTIHYPERTENSIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 68

TABLE 50 UK: ANTIHYPERTENSIVE DRUGS MARKET, BY THERAPEUTIC CLASS, 2020–2027 (USD MILLION) 69

TABLE 51 UK: ANTIHYPERTENSIVE DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 69

TABLE 52 UK: ANTIHYPERTENSIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 70

TABLE 53 ITALY: ANTIHYPERTENSIVE DRUGS MARKET, BY THERAPEUTIC CLASS, 2020–2027 (USD MILLION) 70

TABLE 54 ITALY: ANTIHYPERTENSIVE DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 71

TABLE 55 ITALY: ANTIHYPERTENSIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 71

TABLE 56 SPAIN: ANTIHYPERTENSIVE DRUGS MARKET, BY THERAPEUTIC CLASS, 2020–2027 (USD MILLION) 72

TABLE 57 SPAIN: ANTIHYPERTENSIVE DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 72

TABLE 58 SPAIN: ANTIHYPERTENSIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 73

TABLE 59 REST OF WESTERN EUROPE: ANTIHYPERTENSIVE DRUGS MARKET, BY THERAPEUTIC CLASS, 2020–2027 (USD MILLION) 73

TABLE 60 REST OF WESTERN EUROPE: ANTIHYPERTENSIVE DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 74

TABLE 61 REST OF WESTERN EUROPE: ANTIHYPERTENSIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 74

TABLE 62 EASTERN EUROPE: ANTIHYPERTENSIVE DRUGS MARKET, BY THERAPEUTIC CLASS, 2020–2027 (USD MILLION) 75

TABLE 63 EASTERN EUROPE: ANTIHYPERTENSIVE DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 75

TABLE 64 EASTERN EUROPE: ANTIHYPERTENSIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 76

TABLE 65 ASIA-PACIFIC: ANTIHYPERTENSIVE DRUGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 77

TABLE 66 ASIA-PACIFIC: ANTIHYPERTENSIVE DRUGS MARKET, BY THERAPEUTIC CLASS, 2020–2027 (USD MILLION) 78

TABLE 67 ASIA-PACIFIC: ANTIHYPERTENSIVE DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 78

TABLE 68 ASIA-PACIFIC: ANTIHYPERTENSIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 79

TABLE 69 JAPAN: ANTIHYPERTENSIVE DRUGS MARKET, BY THERAPEUTIC CLASS, 2020–2027 (USD MILLION) 79

TABLE 70 JAPAN: ANTIHYPERTENSIVE DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 80

TABLE 71 JAPAN: ANTIHYPERTENSIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 80

TABLE 72 CHINA: ANTIHYPERTENSIVE DRUGS MARKET, BY THERAPEUTIC CLASS, 2020–2027 (USD MILLION) 81

TABLE 73 CHINA: ANTIHYPERTENSIVE DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 81

TABLE 74 CHINA: ANTIHYPERTENSIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 82

TABLE 75 INDIA: ANTIHYPERTENSIVE DRUGS MARKET, BY THERAPEUTIC CLASS, 2020–2027 (USD MILLION) 82

TABLE 76 INDIA: ANTIHYPERTENSIVE DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 83

TABLE 77 INDIA: ANTIHYPERTENSIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 83

TABLE 78 AUSTRALIA: ANTIHYPERTENSIVE DRUGS MARKET, BY THERAPEUTIC CLASS, 2020–2027 (USD MILLION) 84

TABLE 79 AUSTRALIA: ANTIHYPERTENSIVE DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 84

TABLE 80 AUSTRALIA: ANTIHYPERTENSIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 85

TABLE 81 SOUTH KOREA: ANTIHYPERTENSIVE DRUGS MARKET, BY THERAPEUTIC CLASS, 2020–2027 (USD MILLION) 85

TABLE 82 SOUTH KOREA: ANTIHYPERTENSIVE DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 86

TABLE 83 SOUTH KOREA: ANTIHYPERTENSIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 86

TABLE 84 REST OF ASIA-PACIFIC: ANTIHYPERTENSIVE DRUGS MARKET, BY THERAPEUTIC CLASS, 2020–2027 (USD MILLION) 87

TABLE 85 REST OF ASIA-PACIFIC: ANTIHYPERTENSIVE DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 87

TABLE 86 REST OF ASIA-PACIFIC: ANTIHYPERTENSIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 88

TABLE 87 MIDDLE EAST & AFRICA: ANTIHYPERTENSIVE DRUGS MARKET, BY REGION, 2020–2027 (USD MILLION) 89

TABLE 88 MIDDLE EAST & AFRICA: ANTIHYPERTENSIVE DRUGS MARKET, BY THERAPEUTIC CLASS, 2020–2027 (USD MILLION) 90

TABLE 89 MIDDLE EAST & AFRICA: ANTIHYPERTENSIVE DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 90

TABLE 90 MIDDLE EAST & AFRICA: ANTIHYPERTENSIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 91

TABLE 91 MIDDLE EAST: ANTIHYPERTENSIVE DRUGS MARKET, BY THERAPEUTIC CLASS, 2020–2027 (USD MILLION) 91

TABLE 92 MIDDLE EAST: ANTIHYPERTENSIVE DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 92

TABLE 93 MIDDLE EAST: ANTIHYPERTENSIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 92

TABLE 94 AFRICA: ANTIHYPERTENSIVE DRUGS MARKET, BY THERAPEUTIC CLASS, 2020–2027 (USD MILLION) 93

TABLE 95 AFRICA: ANTIHYPERTENSIVE DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 93

TABLE 96 AFRICA: ANTIHYPERTENSIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 94

15 List of Figures

FIGURE 1 GLOBAL ANTIHYPERTENSIVE DRUGS MARKET: MARKET STRUCTURE 18

FIGURE 2 RESEARCH PROCESS OF MRFR 20

FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACHES 22

FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL ANTIHYPERTENSIVE DRUGS MARKET 24

FIGURE 5 VALUE CHAIN: GLOBAL ANTIHYPERTENSIVE DRUGS MARKET 28

FIGURE 6 PORTER’S FIVE FORCES ANALYSIS: GLOBAL ANTIHYPERTENSIVE DRUGS MARKET 29

FIGURE 7 GLOBAL ANTIHYPERTENSIVE DRUGS MARKET, BY THERAPEUTIC CLASS, 2020 AND 2027 (USD MILLION) 33

FIGURE 8 GLOBAL ANTIHYPERTENSIVE DRUGS MARKET, BY TYPE, 2020 AND 2027 (USD MILLION) 42

FIGURE 9 GLOBAL ANTIHYPERTENSIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020 AND 2027 (USD MILLION) 46

FIGURE 10 GLOBAL ANTIHYPERTENSIVE DRUGS MARKET, BY REGION, 2020 AND 2027 (USD MILLION) 50

FIGURE 11 AMERICAS: ANTIHYPERTENSIVE DRUGS MARKET, BY REGION, 2020 (%) 51

FIGURE 12 NORTH AMERICA: ANTIHYPERTENSIVE DRUGS MARKET, BY COUNTRY, 2020 (%) 53

FIGURE 13 EUROPE: ANTIHYPERTENSIVE DRUGS MARKET, BY REGION, 2020 (%) 61

FIGURE 14 WESTERN EUROPE: ANTIHYPERTENSIVE DRUGS MARKET, BY COUNTRY, 2020 (%) 63

FIGURE 15 ASIA-PACIFIC: ANTIHYPERTENSIVE DRUGS MARKET, BY COUNTRY, 2020 (%) 77

FIGURE 16 MIDDLE EAST & AFRICA: ANTIHYPERTENSIVE DRUGS MARKET, BY REGION, 2020 (%) 89

FIGURE 17 GLOBAL ANTIHYPERTENSIVE DRUGS MARKET: COMPANY SHARE ANALYSIS, 2020 (%) 96